Annual Drug Patent Expirations for LENVIMA Lenvima is a drug marketed by Eisai Inc and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post New patent for Eisai Inc drug LENVIMA appeared first on DrugPatentWat…
ABILIFY (aripiprazole) Otsuka Patent: 8,518,421 Expiration: Jul 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of July 18, 2021 Read Post »
Annual Drug Patent Expirations for XPOVIO Xpovio is a drug marketed by Karyopharm Theraps and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent for Karyopharm Theraps drug XPOVIO appeared first on D…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
Annual Drug Patent Expirations for GOCOVRI Gocovri is a drug marketed by Adamas Pharma and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent for Adamas Pharma drug GOCOVRI appeared first on DrugPa…
This chart shows the pharmaceutical companies with the most pellets dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most pellets dosed drugs…
The post Which pharmaceutical companies have the most pell…
Which pharmaceutical companies have the most pellets dosed drugs? Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are eight…
The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on Dr…
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on DrugP…
Annual Drug Patent Expirations for SOLOSEC Solosec is a drug marketed by Lupin and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for LUPIN drug SOLOSEC appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for EMPAVELI Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent for Apellis Pharms drug EMPAVELI appeared first on Drug…
Get new actionable insights and updates from BiotechBlog
